"More than one or two jurisdictions have changed their stance...
Category:
Regulation
Latest
Sebi mulls safe UPI payment mechanism for registered market intermediaries
This initiative will enable investors to verify the authenticity of...
Budget is by the people, for the people, says FM
Finance Minister Nirmala Sitharaman “We have heard the voice of...
Indian drug firms recall various products in US market
As per the USFDA, the company is recalling the product due to deviation from the current good manufacturing practices (CGMP).
“FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level,” it noted.
China regulator says financial innovation must not create oligopolies
Xiao Yuanqi, chief risk officer at the China Banking and Insurance Regulatory Commission (CBRIC) told the Caixin Summit in Beijing that innovation should not undermine healthy competition or let innovation pioneers become hindrances to further innovation.
Swiss financial market supervisor sees pandemic’s strain lasting
Banks — especially Switzerland’s two big banks, UBS and Credit Suisse — were exposed to heightened risks of debtor bankruptcies and writedowns on loans to corporate clients outside Switzerland, which has experienced a less pronounced downturn than many other countries
IRDAI allows e-signature of customers for buying life insurance policies till March 2021
The insurance agents can’t solicit non-single premium unit-linked insurance policies for annualized premium exceeding Rs.50,000 or single premium unit-linked insurance policies exceeding Rs. 1,00,000.
Europe charges Amazon with using its dominance and data to squeeze rivals
The regulator looked into how the company collects data on competitors that sell on its platform, offering everything from electronics and toys to food and kitchenware. It says that Amazon uses that sensitive information, which shows what is proving popular or not, to better target its own products.
Still no clarity from UK to assess financial market access, says EU
With less than two months before Britain’s full access to the EU ends under post-Brexit transition arrangements on Dec. 31, London’s giant financial hub faces being largely cut off from its biggest customer.
Britain’s finance minister, Rishi Sunak, said on Monday he would not wait for Brussels to decide on UK access and would instead unilaterally allow EU financial firms to offer selected services to UK customers from January.
Much at stake as Supreme Court weighs future of ‘Obamacare’
What’s at stake has real-world consequences for just about every American, as well as the health care industry, a major source of jobs and tax revenues. Whether the Affordable Care Act stays, goes, or is significantly changed, will affect the way life is lived in the US
The argument against the law from the Trump administration and conservative states is that the 10-year-old statute was rendered unconstitutional in its entirety when Congress dialled down to zero a penalty on those remaining uninsured.
President-elect Joe Biden would build on the ACA by improving it and adding a new public health insurance option. But party liberals want a government-run system for all Americans, including the 160 million covered through employer plans.
Sebi asks financial sector organisations to ensure compliance with CERT-In advisory
Among others, they were also advised to ensure complete protection and seamless control over their critical system by continuous monitoring through direct control and supervision protocol mechanisms while keeping such data within the legal boundary of India.
IRDAI forms panel to modify engineering retail segment products
Among the issues, the panel will revisit the product structures of the erstwhile engineering tariffs relevant for the retail category and make suitable recommendations for revising them.
IRDAI unveils draft norms on shareholders’ compensation post M & A of insurers
The Insurance Act, 1938 has laid down that every policyholder or shareholder or member of each of the insurers, before amalgamation, will have the same interest in, or rights against the insurer resulting from amalgamation as he had in the company of which he was originally a policyholder or shareholder or member